Could it be magic? A potential future for users of type 1 diabetes technology…
Imagine, for a moment that that you’re walking down the street and all of a sudden an alert appears in the corner of your vision […]
Diabetes
Adding to the arsenal – what is the new oral add-on for Type 1 Diabetes?
For the first time, an oral add-on treatment, Dapagliflozin (aka Forxiga from Astra Zeneca) has received regulatory approval for managing type 1 diabetes. While this […]
Masquerades and Feints – using DIY diabetes terms nefariously
That’s a very blunt headline making a pretty clear statement about my point of view on this topic, but what is the topic? If you […]
#FreeStyleLibre2 – further thoughts
The big question that remains for many more technical users in relation to the FreeStyle Libre 2 is whether it is transmitting glucose data or […]
Abbott’s #FreestyleLibre2. Announced today at #EASD2018 – more questions than answers…
Abbott’s Freestyle Libre 2. Newly announced at EASD2018. Introducing bluetooth connectivity and real-time alarms.
When we talk about complications, we need to talk about “Risk” #TalkAboutComplications
It’s hard not to have seen the recent Twitter and blog campaign that came about as the result of Grumpy Pumper’s diagnosis of a foot […]
#DIYAPS use in the UK – A Snapshot
In the UK, at least 82 people (as of the date of publishing) are using DIY APS systems to manage their diabetes. Of these, the majority are using AndroidAPS.
A month with Medtrum’s A6 CGM
With two sensors now used and a month of data captured, I felt it was time for further feedback on the newest CGM system on […]
Is Hba1C a poor yardstick for determining access to new T1D treatments in the real world
If you’ve ever looked at a clinical trials document for a type 1 treatment, you’ll nearly always spot two things. Reduction in Hba1C is a […]
Rise of the Machines – Technology and “patient-driven” innovation in the treatment of diabetes #T1DRoM
On Saturday, if you didn’t know already, we ran a first for the UK. A day’s conference focusing on Diabetes Technology, and majoring on “Patient […]